Try our corporate solution for free!
(212) 419-8286

COVID-19 vaccines by contract size in doses by country and manufacturer 2021

As of the beginning of 2021, India has secured some 2.2 billion COVID-19 vaccine doses through contracts in total. India chose to purchase vaccines manufactured by AstraZeneca (Oxford), Novavax, and the Russian Gamaleya Institute. However, the overwhelming majority of these doses have yet to be produced and delivered. This statistic shows the size of COVID-19 vaccine contracts based on number of doses secured by countries through contracts with manufacturers. The AstraZeneca/Oxford vaccine is by far the most sought COVID-19 vaccine, especially due to its ability to be stored at normal refrigerator temperatures, while other vaccines need ultra cold storage.

Size of COVID-19 vaccine contracts between countries and manufacturers as of January 2021*

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2021



Survey time period

as of January 18, 2021

Supplementary notes

* This is a selection of the most prominent vaccines already approved or on track to be approved.
When country contracts include a range of doses to be purchased, we count the lower number. On Dec. 23, Canada’s contracts were updated to reflect those details verified by the government.The Latin America bloc covers all countries in the region except Brazil. The European Union bloc represents the 27 countries of the European Union. The Covax agreement extends to most countries in the world, including many in Africa that wouldn’t otherwise be covered. Jurisdictions without a population figure, such as Somalia and Syria, have been omitted. The Middle East bloc covers U.A.E., Egypt, Bahrain and Jordan. Partnerships involving local manufacturers are listed under the original vaccine developer.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.